| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10167739 | Otolaryngologia Polska | 2009 | 5 Pages |
Abstract
The expression of cyclin D1 in LSCC does not seem to have a prognostic significance. Overexpression of cyclin B1 may be an indicator of the risk of locoregional recurrence in patient receiving radiotherapy. Thus cyclin B1 detected by immunohistochemistry can be useful for predicting outcome of radiotherapy in patients with LSCC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Dorota Dupla, Marcin FrÄ
czek, Tomasz KrÄcicki, Zbigniew Woźniak,